Delirium, Dementia, Amnestic, Cognitive Disorders  >>  fingolimod  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
fingolimod / Generic mfg.
NCT02021162: Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis

Completed
N/A
50
US
University at Buffalo, Novartis
Multiple Sclerosis, Healthy
09/18
10/18

Download Options